XenoPort's new fumarate analog XP23829 gets United States of America patent for treatment of ... pharmabiz.com ... diagnosis animal studies that compared molar equivalent doses of XP23829 to dimethyl fumarate (DMF), another prodrug of MMF, XP23829 demonstrated type A greater degree of effectiveness in animal models of both multiple sclerosis (MS) and psoriasis . and more » Link To Article
No comments:
Post a Comment